Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pluristem Therapeutics Inc.    PSTI   US72940R1023

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/17/2014 04/21/2014 04/22/2014 04/23/2014 04/24/2014 Date
3.54(c) 3.48(c) 3.71(c) 3.64(c) 3.64 Last
70 175 67 897 214 581 74 136 51 246 Volume
+1.72% -1.69% +6.61% -1.89% 0.00% Change
More quotes
Company
Pluristem Therapeutics, Inc. is a bio-therapeutic company, which develops standardized cell therapy products for the treatment of life threatening diseases. The company's patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a... 
Sector
Biotechnology
Calendar
-
Surperformance© rating of Pluristem Therapeutics Inc
Trading Rating : - Investor Rating :
More about the company
Chart PLURISTEM THERAPEUTICS INC
Duration : Period :
Pluristem Therapeutics Inc Technical Analysis Chart | PSTI | US72940R1023 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 0,38 M
EBIT 2014 -32,2 M
Net income 2014 -31,3 M
Debt 2014 -
Yield 2014 -
Sales 2015 0,44 M
EBIT 2015 -46,2 M
Net income 2015 -44,9 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 671x
Capi. / Sales 2015 578x
Capitalization 252 M
More Financials
Latest news on PLURISTEM THERAPEUTICS INC
2d ago PLURISTEM THERAPEUTICS : and the Alliance for Regenerative Medicine Advocate for..
04/16 PLURISTEM THERAPEUTICS : to Deliver Key Commercialization and Scientific Present..
03/26 PLURISTEM THERAPEUTICS : UK's Minister for Universities and Science, David Wille..
03/25 PLURISTEM THERAPEUTICS : Scientists to Present a Poster on GvHD & Participate in..
03/07 PLURISTEM THERAPEUTICS INC. : Pluristem CEO Zami Aberman to Present on Cell & Ge..
03/06 PLURISTEM THERAPEUTICS INC. : US FDA Approves Pluristem's Commercial Scale Cell ..
02/21 PLURISTEM THERAPEUTICS INC. : Pluristem Therapeutics Granted New Patent amid Pos..
02/20 PLURISTEM THERAPEUTICS INC. : Pluristem Submits FDA Orphan Drug Application for ..
02/18 PLURISTEM THERAPEUTICS INC. : Pluristem Receives Key 3D Cell Expansion Patent in..
02/13 PLURISTEM THERAPEUTICS INC. : Pluristem CEO Zami Aberman to Speak on Panel at 9t..
02/11 PLURISTEM THERAPEUTICS INC. : Medical Key Opinion Leaders in Preeclampsia Join P..
02/05 PLURISTEM THERAPEUTICS INC. : PLURISTEM THERAPEUTICS INC - 10-Q - Management's D..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
Pluristem Therapeutics Inc : Income Statement Evolution
More Financials
EPS Revisions
Pluristem Therapeutics Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF